Summary of Consolidated Business Results for April 1– December 31, 2005
2/16/2006
1) Consolidated Operating Results

April – Dec. 2005
April – Dec. 2004
(Reference)
Fiscal year ended Mar.31, 2005

Net Sales¥ Millions
308,247
280,103369,761
Net Income(Note: Amounts have been rounded off to the nearest million yen.)
Operating Income
Current Profit%¥ Millions%¥ Millions
%
10.0
5,393
10.9
6,534
(15.1)
15.8
4,863
66.9
7,696
46.6
11.4

5,745

36.0

9,170

38.8

Fully Diluted EPS(quarterly)

EPS (Quarterly)¥ Millions%¥¥
April – Dec. 2005
4,380
(15.0)
71.71
April – Dec. 2004
5,150
81.4
90.88
84.11
(Reference)
5,968
72.9
104.34
96.68
Fiscal year ended March 31, 2005
(Notes: Figures Shown in percentage of sales, operating income, and other items show the ratios of sequential changes comparedwith the third quarter of 2004.)
2) Consolidated Financial Position¥ Millions
263,086
232,635¥ Millions
73,54757,028

Shareholder’s Equity
Ratio
%
28.0
24.5

210,478

59,581

28.3

Total Assets
April – Dec. 2005
April – Dec. 2004
(Reference)
Period Ended March 31, 2005Shareholder’s Equity

Shareholder’s Equity
Per Share¥
1,175.73
990.76
1,012.71

3) Consolidated Cash Flows

April – Dec. 2005
April – Dec. 2004
(Reference)
Period Ended March 31, 2005

Net Cash fromOperating Activities¥ Millions(12,787)(5,115)Net Cash Used forInvestment Activities¥ Millions
16,623(4,365)Net Cash Used for
Financial Activities¥ Millions(758)
16,979Balance of Cash and Cash
Equivalents at Term End¥ Millions
8,252
13,153(1,675)(7,227)

8,312

5,014

4) Consolidated Forecasts for the Year Ended March 31, 2006 (April 1, 2005 – March 31, 2006)
Current Forecast is amended from the forecast published on November 15, 2005.
Net Sales
Current Profit
Net Income¥ Millions¥ Millions¥ Millions
November Forecast(A)
400,000
7,400
5,700
Current Forecast(B)
410,000
7,400
4,600
Difference(B)-(A)
10,0000(1,100)
Changefrom
November
2.5%(19.3%)
Forecast(Reference) Expected EPS (Whole Year) ¥73.54* The above forecasts were prepared on the basis of information available on the date of release. Actual results may differ from these forecasts due tovarious factors.

5)Business results

The Company aggressively pushed forward business activities focusing on priority areas both at home and abroad
through the third quarter of the current fiscal year. As a result, sales through the third quarter increased to¥308,247 million, up ¥28,144 million over the same quarter of the previous year. For the same period, operating
profit increased to ¥5,393 million, up ¥530 million.
Current profit through the third quarter of the current fiscal year decreased to ¥6,534 million, down ¥1,161
million from the same period of the previous year due to decrease in profit based on the equity method investment
balance, etc. Gain on sales of shares in Sumitomo Pharmaceuticals Co., Ltd. (now Dainippon Sumitomo PharmaCo., Ltd.) and Troon Investments Ltd. was booked as extraordinary gain, but also bad debt reserves and some otherlosses were recorded as extraordinary loss. As a result, after corporate taxes were deducted, net profit through thethird quarter of the current fiscal year decreased to ¥4,380 million, down ¥770 million from the same period of theprevious year.

6) Sales by segment（¥ Millions）
Net sales％

IT&electronics

94,27030.6

Housing Materials

19,241

6.2

Chemicals

52,845

17.1

Plastics

117,031

38.0

Food

17,857

5.8

Misc.

7,000

2.3

Total

308,247

100.0